Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Clinical trial NCT02891460 · COMPLETED

Trial details

NCT number: NCT02891460
Sponsor: UroGen Pharma Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms Urologic Neoplasms Neoplasms Urinary Bladder Diseases Urologic Diseases

Start date: 2013-01-01
Primary completion: 2014-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.